These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33353833)

  • 1. Primary care provider perceptions of an integrated community pharmacy hypertension management program.
    Vordenberg SE; Thompson AN; Vereecke A; Smrke R; Serlin DC; Fan AL; Choe HM
    J Am Pharm Assoc (2003); 2021; 61(3):e107-e113. PubMed ID: 33353833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking the patient-centered medical home to community pharmacy via an innovative pharmacist care model.
    Farris KB; Mitrzyk BM; Batra P; Peters J; Diez HL; Yoo A; McKay K; Friend K; Danko L; Waber R; Marshall VD; Choe HM
    J Am Pharm Assoc (2003); 2019; 59(1):70-78.e3. PubMed ID: 30416067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist engagement in a community pharmacy hypertension management program in collaboration with an academic medical center.
    Vordenberg SE; Kim J; Serlin DC; Fan AL; Choe HM
    Am J Health Syst Pharm; 2022 Jun; 79(13):1110-1114. PubMed ID: 35278307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacist collaboration with a patient-centered medical home: Establishment of a patient-centered medical neighborhood and payment model.
    Luder HR; Shannon P; Kirby J; Frede SM
    J Am Pharm Assoc (2003); 2018; 58(1):44-50. PubMed ID: 29153853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study.
    Brenner AT; Rohweder CL; Wangen M; Atkins DL; Ceballos RM; Correa S; Ferrari RM; Issaka RB; Ittes A; Odebunmi OO; Reuland DS; Waters AR; Wheeler SB; Shah PD
    BMC Health Serv Res; 2023 Aug; 23(1):892. PubMed ID: 37612656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider perceptions of pharmacists providing mental health medication support in patient-centered medical homes.
    Coe AB; Bostwick JR; Choe HM; Thompson AN
    J Am Pharm Assoc (2003); 2019; 59(4):555-559. PubMed ID: 31010786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists.
    Dixon DL; Salgado TM; Caldas LM; Van Tassell BW; Sisson EM
    J Am Pharm Assoc (2003); 2018; 58(4):382-386. PubMed ID: 29804824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and implementation of a collaboration between a patient-centered medical home and community pharmacy.
    Stafford RA; Garrett LN; Bates KA; Diemer TB; Thomas JL; Smith MG; Teeter BS; Curran GM
    J Am Pharm Assoc (2003); 2020; 60(1):122-129. PubMed ID: 31870861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacist's contribution within a patient-centered medical home.
    McConaha JL; Tedesco GW; Civitarese L; Hebda MF
    J Am Pharm Assoc (2003); 2015; 55(3):302-6. PubMed ID: 25909515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of pharmacists into a patient-centered medical home.
    Scott MA; Hitch B; Ray L; Colvin G
    J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of technician-driven medication therapy management program in community pharmacies.
    Burnside TPT; Scott NJ; Smith MG
    J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcomes after a 2-year pharmaceutical care program for patients taking vitamin K antagonist therapy? Community pharmacist's perception].
    Mongaret C; Lepage C; Aubert L; Lestrille A; Slimano F
    Ann Pharm Fr; 2018 Mar; 76(2):114-121. PubMed ID: 29395013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care coordination and follow-up practices in the community pharmacy setting: A mixed methods study.
    Renfro CP; Robinson JM; Turner K; Gaskins T; Ferreri SP
    J Am Pharm Assoc (2003); 2020; 60(4):631-638.e2. PubMed ID: 31919008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "We Need to Taper." Interviews with Clinicians and Pharmacists About Use of a Pharmacy-Led Opioid Tapering Program.
    Firemark AJ; Schneider JL; Kuntz JL; Papajorgji-Taylor D; Dickerson JF; Thorsness LA; Reese KR; Sullivan MD; Debar LL; Smith DH
    Pain Med; 2021 May; 22(5):1213-1222. PubMed ID: 33616160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provider Perception of Pharmacy Services in the Patient-Centered Medical Home.
    Albanese NP; Pignato AM; Monte SV
    J Pharm Pract; 2017 Dec; 30(6):612-620. PubMed ID: 27887032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and feasibility of a community pharmacy-driven 24-hour ambulatory blood pressure monitoring service.
    Dixon DL; Patterson JA; Gatewood S; Kaefer T; Jadallah J; Curtis M; Hawkey L; Grigsby J; Salgado TM; Holdford DA
    J Am Pharm Assoc (2003); 2020; 60(6):e332-e340. PubMed ID: 32665096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient perceptions of a tuberculosis testing program provided in the community pharmacy setting.
    Jakeman B; Logothetis SJ; Saba M; Anderson D; Acosta JM; Borrego ME; Roberts MH; Bachyrycz A; Fortune D; Burgos M
    Public Health; 2020 Apr; 181():135-140. PubMed ID: 32014641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.